Update on New and Emerging Therapies in the Management of Psoriasis.

Abstract

Tumor necrosis factor inhibitors are a mainstay of treatment for patients with psoriasis who require systemic therapy. Since the approval of several of these agents, other biologic agents and small molecules have been developed; some of these have been approved recently by the US Food and Drug Administration, and others have shown great promise in clinical… (More)
DOI: 10.12788/j.sder.2015.0136

Topics

Cite this paper

@article{Gordon2015UpdateON, title={Update on New and Emerging Therapies in the Management of Psoriasis.}, author={Kenneth B. Gordon}, journal={Seminars in cutaneous medicine and surgery}, year={2015}, volume={34 2 Suppl}, pages={S34-6} }